Global Opioids Market Research Report 2023

Global Opioids Market Research Report 2023

Table of Contents
1 Opioids Market Overview
1.1 Product Overview and Scope of Opioids
1.2 Opioids Segment by Type
1.2.1 Global Opioids Market Value Comparison by Type (2023-2029)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Opioids Segment by Application
1.3.1 Global Opioids Market Value by Application: (2023-2029)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Global Opioids Market Size Estimates and Forecasts
1.4.1 Global Opioids Revenue 2018-2029
1.4.2 Global Opioids Sales 2018-2029
1.4.3 Global Opioids Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Opioids Market Competition by Manufacturers
2.1 Global Opioids Sales Market Share by Manufacturers (2018-2023)
2.2 Global Opioids Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Opioids Average Price by Manufacturers (2018-2023)
2.4 Global Opioids Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioids, Product Type & Application
2.7 Opioids Market Competitive Situation and Trends
2.7.1 Opioids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioids Players Market Share by Revenue
2.7.3 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioids Retrospective Market Scenario by Region
3.1 Global Opioids Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Opioids Global Opioids Sales by Region: 2018-2029
3.2.1 Global Opioids Sales by Region: 2018-2023
3.2.2 Global Opioids Sales by Region: 2024-2029
3.3 Global Opioids Global Opioids Revenue by Region: 2018-2029
3.3.1 Global Opioids Revenue by Region: 2018-2023
3.3.2 Global Opioids Revenue by Region: 2024-2029
3.4 North America Opioids Market Facts & Figures by Country
3.4.1 North America Opioids Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Opioids Sales by Country (2018-2029)
3.4.3 North America Opioids Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioids Market Facts & Figures by Country
3.5.1 Europe Opioids Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Opioids Sales by Country (2018-2029)
3.5.3 Europe Opioids Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioids Market Facts & Figures by Country
3.6.1 Asia Pacific Opioids Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Opioids Sales by Country (2018-2029)
3.6.3 Asia Pacific Opioids Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioids Market Facts & Figures by Country
3.7.1 Latin America Opioids Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Opioids Sales by Country (2018-2029)
3.7.3 Latin America Opioids Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioids Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioids Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Opioids Sales by Country (2018-2029)
3.8.3 Middle East and Africa Opioids Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioids Sales by Type (2018-2029)
4.1.1 Global Opioids Sales by Type (2018-2023)
4.1.2 Global Opioids Sales by Type (2024-2029)
4.1.3 Global Opioids Sales Market Share by Type (2018-2029)
4.2 Global Opioids Revenue by Type (2018-2029)
4.2.1 Global Opioids Revenue by Type (2018-2023)
4.2.2 Global Opioids Revenue by Type (2024-2029)
4.2.3 Global Opioids Revenue Market Share by Type (2018-2029)
4.3 Global Opioids Price by Type (2018-2029)
5 Segment by Application
5.1 Global Opioids Sales by Application (2018-2029)
5.1.1 Global Opioids Sales by Application (2018-2023)
5.1.2 Global Opioids Sales by Application (2024-2029)
5.1.3 Global Opioids Sales Market Share by Application (2018-2029)
5.2 Global Opioids Revenue by Application (2018-2029)
5.2.1 Global Opioids Revenue by Application (2018-2023)
5.2.2 Global Opioids Revenue by Application (2024-2029)
5.2.3 Global Opioids Revenue Market Share by Application (2018-2029)
5.3 Global Opioids Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Opioids Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Purdue Pharma Opioids Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Mallinckrodt Opioids Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amneal Pharma Opioids Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Collegium Opioids Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Sales, Revenue and Gross Margin (2018-2023)
6.6.4 J&J Opioids Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Endo Opioids Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Opioids Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2018-2023)
6.9.4 INSYS Opioids Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mylan Opioids Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Description and Business Overview
6.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hikma Opioids Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Description and Business Overview
6.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Egalet Opioids Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioids Industry Chain Analysis
7.2 Opioids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioids Production Mode & Process
7.4 Opioids Sales and Marketing
7.4.1 Opioids Sales Channels
7.4.2 Opioids Distributors
7.5 Opioids Customers
8 Opioids Market Dynamics
8.1 Opioids Industry Trends
8.2 Opioids Market Drivers
8.3 Opioids Market Challenges
8.4 Opioids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Opioids Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Opioids Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Opioids Market Competitive Situation by Manufacturers in 2022
Table 4. Global Opioids Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global Opioids Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Opioids Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Opioids Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Opioids Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Opioids, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Opioids, Product Type & Application
Table 12. Global Key Manufacturers of Opioids, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Opioids Sales by Region (2018-2023) & (MT)
Table 18. Global Opioids Sales Market Share by Region (2018-2023)
Table 19. Global Opioids Sales by Region (2024-2029) & (MT)
Table 20. Global Opioids Sales Market Share by Region (2024-2029)
Table 21. Global Opioids Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Opioids Revenue Market Share by Region (2018-2023)
Table 23. Global Opioids Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Opioids Revenue Market Share by Region (2024-2029)
Table 25. North America Opioids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Opioids Sales by Country (2018-2023) & (MT)
Table 27. North America Opioids Sales by Country (2024-2029) & (MT)
Table 28. North America Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Opioids Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Opioids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Opioids Sales by Country (2018-2023) & (MT)
Table 32. Europe Opioids Sales by Country (2024-2029) & (MT)
Table 33. Europe Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Opioids Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Opioids Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Opioids Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific Opioids Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Opioids Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Opioids Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Opioids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Opioids Sales by Country (2018-2023) & (MT)
Table 42. Latin America Opioids Sales by Country (2024-2029) & (MT)
Table 43. Latin America Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Opioids Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Opioids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Opioids Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa Opioids Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Opioids Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Opioids Sales (MT) by Type (2018-2023)
Table 51. Global Opioids Sales (MT) by Type (2024-2029)
Table 52. Global Opioids Sales Market Share by Type (2018-2023)
Table 53. Global Opioids Sales Market Share by Type (2024-2029)
Table 54. Global Opioids Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Opioids Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Opioids Revenue Market Share by Type (2018-2023)
Table 57. Global Opioids Revenue Market Share by Type (2024-2029)
Table 58. Global Opioids Price (USD/Kg) by Type (2018-2023)
Table 59. Global Opioids Price (USD/Kg) by Type (2024-2029)
Table 60. Global Opioids Sales (MT) by Application (2018-2023)
Table 61. Global Opioids Sales (MT) by Application (2024-2029)
Table 62. Global Opioids Sales Market Share by Application (2018-2023)
Table 63. Global Opioids Sales Market Share by Application (2024-2029)
Table 64. Global Opioids Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Opioids Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Opioids Revenue Market Share by Application (2018-2023)
Table 67. Global Opioids Revenue Market Share by Application (2024-2029)
Table 68. Global Opioids Price (USD/Kg) by Application (2018-2023)
Table 69. Global Opioids Price (USD/Kg) by Application (2024-2029)
Table 70. Teva Corporation Information
Table 71. Teva Description and Business Overview
Table 72. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. Teva Opioids Product
Table 74. Teva Recent Developments/Updates
Table 75. Purdue Pharma Corporation Information
Table 76. Purdue Pharma Description and Business Overview
Table 77. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. Purdue Pharma Opioids Product
Table 79. Purdue Pharma Recent Developments/Updates
Table 80. Mallinckrodt Corporation Information
Table 81. Mallinckrodt Description and Business Overview
Table 82. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. Mallinckrodt Opioids Product
Table 84. Mallinckrodt Recent Developments/Updates
Table 85. Amneal Pharma Corporation Information
Table 86. Amneal Pharma Description and Business Overview
Table 87. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Amneal Pharma Opioids Product
Table 89. Amneal Pharma Recent Developments/Updates
Table 90. Collegium Corporation Information
Table 91. Collegium Description and Business Overview
Table 92. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. Collegium Opioids Product
Table 94. Collegium Recent Developments/Updates
Table 95. J&J Corporation Information
Table 96. J&J Description and Business Overview
Table 97. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. J&J Opioids Product
Table 99. J&J Recent Developments/Updates
Table 100. Endo Corporation Information
Table 101. Endo Description and Business Overview
Table 102. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Endo Opioids Product
Table 104. Endo Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. Pfizer Opioids Product
Table 109. Pfizer Recent Developments/Updates
Table 110. INSYS Corporation Information
Table 111. INSYS Description and Business Overview
Table 112. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. INSYS Opioids Product
Table 114. INSYS Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Mylan Opioids Product
Table 119. Mylan Recent Developments/Updates
Table 120. Hikma Corporation Information
Table 121. Hikma Description and Business Overview
Table 122. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Hikma Opioids Product
Table 124. Hikma Recent Developments/Updates
Table 125. Egalet Corporation Information
Table 126. Egalet Description and Business Overview
Table 127. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Egalet Opioids Product
Table 129. Egalet Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Opioids Distributors List
Table 133. Opioids Customers List
Table 134. Opioids Market Trends
Table 135. Opioids Market Drivers
Table 136. Opioids Market Challenges
Table 137. Opioids Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioids
Figure 2. Global Opioids Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Opioids Market Share by Type in 2022 & 2029
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Other Product Picture
Figure 9. Global Opioids Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Opioids Market Share by Application in 2022 & 2029
Figure 11. Pain Relief
Figure 12. Anesthesia
Figure 13. Cough Suppression
Figure 14. Diarrhea Suppression
Figure 15. Deaddiction
Figure 16. Others
Figure 17. Global Opioids Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Opioids Market Size (2018-2029) & (US$ Million)
Figure 19. Global Opioids Sales (2018-2029) & (MT)
Figure 20. Global Opioids Average Price (USD/Kg) & (2018-2029)
Figure 21. Opioids Report Years Considered
Figure 22. Opioids Sales Share by Manufacturers in 2022
Figure 23. Global Opioids Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Opioids Players: Market Share by Revenue in 2022
Figure 25. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Opioids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Opioids Sales Market Share by Country (2018-2029)
Figure 28. North America Opioids Revenue Market Share by Country (2018-2029)
Figure 29. U.S. Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Opioids Sales Market Share by Country (2018-2029)
Figure 32. Europe Opioids Revenue Market Share by Country (2018-2029)
Figure 33. Germany Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Opioids Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Opioids Revenue Market Share by Region (2018-2029)
Figure 40. China Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Taiwan Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Philippines Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America Opioids Sales Market Share by Country (2018-2029)
Figure 51. Latin America Opioids Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Opioids Sales Market Share by Country (2018-2029)
Figure 56. Middle East & Africa Opioids Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. U.A.E Opioids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Sales Market Share of Opioids by Type (2018-2029)
Figure 61. Global Revenue Market Share of Opioids by Type (2018-2029)
Figure 62. Global Opioids Price (USD/Kg) by Type (2018-2029)
Figure 63. Global Sales Market Share of Opioids by Application (2018-2029)
Figure 64. Global Revenue Market Share of Opioids by Application (2018-2029)
Figure 65. Global Opioids Price (USD/Kg) by Application (2018-2029)
Figure 66. Opioids Value Chain
Figure 67. Opioids Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs